Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Resmed Inc shares valued at $497,660 were sold by FARRELL PETER C on Jan 07 ’26. At $248.83 per share, FARRELL PETER C sold 2,000 shares. The insider’s holdings dropped to 66,773 shares worth approximately $17.31 million following the completion of this transaction.
Also, Farrell Michael J. sold 4,991 shares, netting a total of over 1,240,065 in proceeds. Following the sale of shares at $248.46 each, the insider now holds 466,223 shares.
Before that, Peter C Farrell had added 2,000 shares to its account. In a trade valued at $497,580, the Director bought Resmed Inc shares for $248.79 each.
As published in a research note from Robert W. Baird on December 16, 2025, Resmed Inc [RMD] has been rated down from an Outperform to a Neutral and the price target has been revised to $275. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in mid September. As of September 02, 2025, CLSA has increased its “Hold” rating to a “an Outperform” for RMD. Earlier on July 15, 2025, RBC Capital Mkts upgraded its rating. Their new recommendation was “an Outperform” for RMD stock which previously was a “a Sector perform”.
Analyzing RMD Stock Performance
On last trading session, Resmed Inc [NYSE: RMD] rose 2.41% to $259.28. The stock’s lowest price that day was $253.0, but it reached a high of $260.8399 in the same session. During the last five days, there has been a surge of approximately 1.81%. Over the course of the year, Resmed Inc shares have jumped approximately 8.13%.
Is Resmed Inc subject to short interest?
Stocks of Resmed Inc saw a sharp rise in short interest on 2025-12-31 jumping by 1.26 million shares to 11.67 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 10.42 million shares. A jump of 10.76% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 12.72 of the overall float, the days-to-cover ratio (short ratio) jumped to 12.72.
Which companies own the most shares of Resmed Inc (RMD)?
In terms of Resmed Inc share price expectations, FactSet research, analysts set an average price target of 289.5 in the next 12 months, up nearly 14.34% from the previous closing price of $253.19. Analysts anticipate Resmed Inc stock to reach 345 by 2026, with the lowest price target being 260. In spite of this, 19 analysts ranked Resmed Inc stock as Buy at the end of 2026. On March 19, 2025, Morgan Stanley assigned a price target of “an Overweight” to the stock and initiated coverage with a $280.
